FDA
-
-
-
-
-
-
-
Aurigene reports 63.6% response rate in early cancer drug trial
-
-
-
-
-
-
-
Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
-
-
-
-
-
-
-
Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of
-
-
-
-
-
-
-
Dr. Reddy’s Announces the First-to-Market Launch of Over-the-Counter, Store-Brand Equivalent of Allegra-D® 24 Hr in the U.S. Market
-
-
-
-
-
-
-
Dr. Reddy's Laboratories Announces the Launch of Pemetrexed for Injection USP, in the U.S. Market
-
-
-
-
-
-
-
Dr. Reddys Labs (RDY) has received FDA approval for VeraRing
-
-
-
-
-
-
-
Dr. Reddys Labs (RDY) Announces FDA Approval of Lenalidomide Capsules
-
335,960 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


